Universe Pharmaceuticals (UPC) Competitors $4.01 -0.07 (-1.72%) As of 09/12/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock UPC vs. OBSV, KZIA, SNOA, BMRA, GNPX, VYNE, ADIL, MYNZ, CYCN, and CEROShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include ObsEva (OBSV), Novogen (KZIA), Sonoma Pharmaceuticals (SNOA), Biomerica (BMRA), Genprex (GNPX), VYNE Therapeutics (VYNE), Adial Pharmaceuticals (ADIL), Mainz Biomed (MYNZ), Cyclerion Therapeutics (CYCN), and CERo Therapeutics (CERO). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. Its Competitors ObsEva Novogen Sonoma Pharmaceuticals Biomerica Genprex VYNE Therapeutics Adial Pharmaceuticals Mainz Biomed Cyclerion Therapeutics CERo Therapeutics ObsEva (NASDAQ:OBSV) and Universe Pharmaceuticals (NASDAQ:UPC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation. Do institutionals and insiders believe in OBSV or UPC? 17.5% of ObsEva shares are held by institutional investors. Comparatively, 0.2% of Universe Pharmaceuticals shares are held by institutional investors. 14.4% of ObsEva shares are held by company insiders. Comparatively, 57.4% of Universe Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is OBSV or UPC more profitable? Universe Pharmaceuticals' return on equity of 0.00% beat ObsEva's return on equity.Company Net Margins Return on Equity Return on Assets ObsEvaN/A -416.36% -92.01% Universe Pharmaceuticals N/A N/A N/A Does the media favor OBSV or UPC? In the previous week, Universe Pharmaceuticals had 3 more articles in the media than ObsEva. MarketBeat recorded 3 mentions for Universe Pharmaceuticals and 0 mentions for ObsEva. Universe Pharmaceuticals' average media sentiment score of 0.33 beat ObsEva's score of 0.00 indicating that Universe Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment ObsEva Neutral Universe Pharmaceuticals Neutral Which has more risk & volatility, OBSV or UPC? ObsEva has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Universe Pharmaceuticals has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500. Which has better valuation & earnings, OBSV or UPC? Universe Pharmaceuticals has higher revenue and earnings than ObsEva. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioObsEvaN/AN/A-$58.38M-$0.92N/AUniverse Pharmaceuticals$19.29M0.12-$8.73MN/AN/A SummaryUniverse Pharmaceuticals beats ObsEva on 8 of the 9 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.26M$2.59B$5.84B$10.14BDividend YieldN/A56.52%5.68%4.60%P/E RatioN/A23.8575.4125.98Price / Sales0.12529.66515.81181.13Price / CashN/A171.1637.5660.44Price / Book0.005.3712.156.29Net Income-$8.73M$32.95M$3.29B$271.07M7 Day Performance12.96%1.28%0.73%3.87%1 Month Performance12.64%5.61%4.99%5.49%1 Year PerformanceN/A-1.67%62.53%25.86% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse Pharmaceuticals0.9569 of 5 stars$4.01-1.7%N/AN/A$2.26M$19.29M0.00220Short Interest ↓OBSVObsEvaN/AN/AN/AN/A$7.94MN/A0.0050KZIANovogen3.684 of 5 stars$7.76-4.1%$14.00+80.4%-52.9%$7.82M$2.31M0.0012News CoverageShort Interest ↓Gap DownSNOASonoma Pharmaceuticals0.7915 of 5 stars$4.73+4.4%N/A+27.7%$7.77M$14.29M-1.92180BMRABiomerica0.6975 of 5 stars$2.75-2.5%N/A+22.9%$7.74M$5.31M-1.1960Short Interest ↓Gap DownGNPXGenprex1.2345 of 5 stars$0.23+47.4%N/A-30.5%$7.68MN/A0.0020News CoverageShort Interest ↑High Trading VolumeVYNEVYNE Therapeutics2.7826 of 5 stars$0.30-3.6%$6.25+1,988.9%-83.1%$7.62M$476K-0.3330News CoverageShort Interest ↓ADILAdial Pharmaceuticals2.9727 of 5 stars$0.35+0.6%$8.00+2,195.6%-67.6%$7.61MN/A-0.3320Short Interest ↓MYNZMainz Biomed3.1034 of 5 stars$1.63-3.0%$14.00+758.9%-86.4%$7.46M$890K-0.0230Short Interest ↓CYCNCyclerion Therapeutics1.5394 of 5 stars$2.23-6.7%N/A-12.8%$7.39M$2.17M-3.0130Short Interest ↑CEROCERo Therapeutics3.563 of 5 stars$5.92-14.6%$45.00+660.1%-97.1%$7.14MN/A0.008High Trading Volume Related Companies and Tools Related Companies ObsEva Alternatives Novogen Alternatives Sonoma Pharmaceuticals Alternatives Biomerica Alternatives Genprex Alternatives VYNE Therapeutics Alternatives Adial Pharmaceuticals Alternatives Mainz Biomed Alternatives Cyclerion Therapeutics Alternatives CERo Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UPC) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UPC Stock Alerts